HI-LEA Trademark

Trademark Overview

On Friday, December 14, 2018, a trademark application was filed for HI-LEA with the United States Patent and Trademark Office. The USPTO has given the HI-LEA trademark a serial number of 88230390. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 23, 2022. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The HI-LEA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing educational information regarding ophthalmic diseases and pharmaceutical preparations for the treatment of ophthalmic diseases
hi-lea

General Information

Serial Number88230390
Word MarkHI-LEA
Filing DateFriday, December 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 23, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements

Goods and ServicesProviding educational information regarding ophthalmic diseases and pharmaceutical preparations for the treatment of ophthalmic diseases

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 7, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 23, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU EXTENSION 5 GRANTED
Friday, September 17, 2021SOU EXTENSION 5 FILED
Wednesday, September 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 17, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 15, 2021SOU EXTENSION 4 GRANTED
Monday, March 15, 2021SOU EXTENSION 4 FILED
Monday, March 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2020SOU EXTENSION 3 GRANTED
Monday, September 21, 2020SOU EXTENSION 3 FILED
Monday, September 21, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 27, 2020SOU EXTENSION 2 GRANTED
Friday, March 27, 2020SOU EXTENSION 2 FILED
Friday, March 27, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 11, 2019SOU EXTENSION 1 GRANTED
Friday, October 11, 2019SOU EXTENSION 1 FILED
Friday, October 11, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 8, 2019ASSIGNED TO EXAMINER
Monday, January 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 18, 2018NEW APPLICATION ENTERED

Related Keywords

diseases ophthalmic preparations treatment pharmaceutical educational regarding providing information